News

A research group has discovered the mechanism by which the Rhesus macaque Macaca mulatta naturally develops a lasting immune response against schistosomiasis.

Researchers have found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2.

Scientists have pinpointed a gene that helps deadly E. coli bacteria evade antibiotics, potentially leading to better treatments for millions of people worldwide.

A nanotherapeutic microRNA drug has been developed to prevent cancer from spreading to the liver.

Testing drug sensitivity on tumor tissue at physiological oxygen levels could act as a new screening method for drug efficacy.

A computational biology researcher has reported a cross-reaction between Bacillus Calmette-Guérin and SARS-CoV-2 that might help explain what could be driving immunity brought on by the BCG vaccination.

The World Health Organization (WHO) has strongly recommended the drug baricitinib for patients with severe or critical COVID-19 in combination with corticosteroids. In the same guideline update, it also makes a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe disease, but only in those at the highest risk of hospitalization.

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster their defenses against skin cancer.

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV.

New research indicates kidney damage could be a potential long-term effect of medications that combat high blood pressure.